What is the Nephrocare Health Services Ltd share price today?

The share price of NSE:NEPHROPLUS-EQ on 01 Oct 2026 (as of 15:04:23 IST) is ₹648.6.

What is the NSE:NEPHROPLUS-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:NEPHROPLUS-EQ 52 week high low range shows a high of ₹781.5 and a low of ₹446.

What is the Nephrocare Health Services Ltd market cap?

As on 01 Oct 2026, Nephrocare Health Services Ltd market cap is ₹66379000000.

What is the shareholding pattern of Nephrocare Health Services Ltd Stock?

The shareholding pattern of Nephrocare Health Services Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 63.85% Foreign Institutional Investors (FII): 8.78% Domestic Institutional Investors (DII): 5.85% Mutual Funds: 3.2% Retail & Others: 18.32% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Nephrocare Health Services Ltd?

The Price-to-Earnings (PE) ratio of Nephrocare Health Services Ltd is 86.386, and the Price-to-Book (PB) ratio is 4.6179, as on 01 Oct 2026.

Nephrocare Health Services Share Price

630.25+5.65 (+0.90%)

+33.74% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+0.90%

1 Week

+2.55%

1 Month

-1.16%

3 Month

-8.88%

6 Month

+15.65%

YTD

+34.47%

1 Year

5 Year

10 Year

Max

+28.62%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

585.50

580.20

536.00

446.00

High

632.25

634.35

647.55

781.50

About

Nephrocare Health Services is engaged in offering comprehensive dialysis care through its network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported Read more

Hospital & Healthcare Services

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

APOLLOHOSPNSE

MAXHEALTHNSE

MANIPALHOSNSE

ASTERDMNSE

FORTISNSE

NHNSE

MEDANTANSE

LALPATHLABNSE

KIMSNSE

AGARWALEYENSE

NEPHROPLUSNSE

LTP

1W Low

1W High

Market cap (₹)

8542+94 (1.11%)

8301

8575

1,21,412Cr

918.7+58.7 (6.83%)

863.80

926.70

87,015Cr

658.15-11 (-1.64%)

633.25

665.95

84,796Cr

685.4+4.25 (0.62%)

672

690.75

59,431Cr

792.5+24.35 (3.17%)

754.65

795.50

59,227Cr

1913.2+193 (11.22%)

1732.50

1926

38,205Cr

1388.1+117.8 (9.27%)

1270.30

1397.80

35,671Cr

1913.8+7.4 (0.39%)

1856.50

1936

32,373Cr

735.6+33.8 (4.82%)

702.40

738.50

30,682Cr

521.95+12.75 (2.50%)

502

525.50

16,250Cr

596.45-18.1 (-2.95%)

595.25

634.35

6,283Cr

Nephrocare Health Services Share Price

630.25+5.65 (+0.90%)

+33.74% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years32%

Last year32%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year15%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year-

Return on Equity

10 years7%

5 years7%

3 years11%

Last year9%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	32%	32%
-	-	-	15%
-	-	-	-
7%	7%	11%	9%

Peer Comparison

Symbol

APOLLOHOSP

MAXHEALTH

MANIPALHOS

ASTERDM

FORTIS

MEDANTA

LALPATHLAB

KIMS

AGARWALEYE

NEPHROPLUS

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
8,542	₹121412 Cr	58.11	40.39	207.67	₹1942 Cr
918.7	₹87015 Cr	63.03	4.26	19.36	₹1442 Cr
658.15	₹84796 Cr	95.03	1.96	11.95	₹892 Cr
685.4	₹59431 Cr	186.49	0.31	6.76	₹388 Cr
792.5	₹59227 Cr	56.52	3.53	20.1	₹1042 Cr
1,913.2	₹38205 Cr	44.49	14.73	71.14	₹806 Cr
1,388.1	₹35671 Cr	57.68	8.21	32.95	₹556 Cr
1,913.8	₹32373 Cr	59.74	10.11	42.51	₹505 Cr
735.6	₹30682 Cr	150.18	1.04	12.74	₹241 Cr
521.95	₹16250 Cr	109.52	1.43	13.88	₹133 Cr
596.45	₹6283 Cr	81.77	3.19	16.66	₹77 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Jun 2025	Mar 2025	Dec 2024
₹282 Cr	₹266 Cr	₹260 Cr	₹228 Cr	₹219 Cr	₹197 Cr
₹7 Cr	₹12 Cr	₹3 Cr	₹7 Cr	₹4 Cr	₹5 Cr
₹289 Cr	₹277 Cr	₹263 Cr	₹234 Cr	₹223 Cr	₹203 Cr
₹242 Cr	₹238 Cr	₹221 Cr	₹200 Cr	₹187 Cr	₹171 Cr
₹71 Cr	₹65 Cr	₹64 Cr	₹54 Cr	₹55 Cr	₹49 Cr
₹2 Cr	₹3 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr
₹45 Cr	₹36 Cr	₹36 Cr	₹29 Cr	₹30 Cr	₹26 Cr
₹36 Cr	₹33 Cr	₹32 Cr	₹24 Cr	₹25 Cr	₹20 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Less Impairment of Assets

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023
—	—	—	—
₹20 Cr	₹5 Cr	₹5 Cr	₹5 Cr
₹18 Cr	₹13 Cr	₹6 Cr	₹8 Cr
₹1078 Cr	₹566 Cr	₹402 Cr	₹375 Cr
₹1078 Cr	₹566 Cr	₹402 Cr	₹375 Cr
₹1116 Cr	₹584 Cr	₹414 Cr	₹389 Cr
₹5 L	₹96 Cr	₹123 Cr	₹81 Cr
-₹30 Cr	-₹19 Cr	-₹23 Cr	-₹17 Cr
₹46 Cr	₹26 Cr	₹23 Cr	₹17 Cr
₹6 Cr	₹5 Cr	₹3 Cr	₹4 Cr
₹21 Cr	₹108 Cr	₹126 Cr	₹86 Cr
—	—	—	—
₹143 Cr	₹113 Cr	₹71 Cr	₹43 Cr
₹124 Cr	₹63 Cr	₹78 Cr	₹38 Cr
₹13 Cr	₹101 Cr	₹93 Cr	₹92 Cr
₹19 Cr	₹7 Cr	₹1 Cr	₹1 Cr
₹299 Cr	₹284 Cr	₹243 Cr	₹175 Cr
₹1437 Cr	₹976 Cr	₹782 Cr	₹650 Cr
₹23 Cr	₹226 Cr	₹243 Cr	₹196 Cr
—	—	—	—
₹841 Cr	₹679 Cr	₹564 Cr	₹386 Cr
₹323 Cr	₹282 Cr	₹208 Cr	₹146 Cr
₹1 Cr	₹0	₹0	₹0
₹517 Cr	₹396 Cr	₹356 Cr	₹239 Cr
₹6 Cr	₹6 Cr	₹69 L	₹32 Cr
₹7 Cr	₹0	₹0	₹0
₹7 Cr	₹0	₹0	₹0
₹23 Cr	₹10 Cr	₹16 Cr	₹10 Cr
₹46 Cr	₹18 Cr	₹20 Cr	₹42 Cr
₹598 Cr	₹431 Cr	₹392 Cr	₹325 Cr
—	—	—	—
₹171 Cr	₹51 Cr	₹0	₹0
₹33 Cr	₹27 Cr	₹26 Cr	₹26 Cr
₹317 Cr	₹266 Cr	₹203 Cr	₹159 Cr
₹255 Cr	₹155 Cr	₹61 Cr	₹14 Cr
₹8 Cr	₹6 Cr	₹7 Cr	₹4 Cr
₹56 Cr	₹40 Cr	₹94 Cr	₹121 Cr
₹839 Cr	₹545 Cr	₹390 Cr	₹324 Cr
₹540 Cr	₹261 Cr	₹147 Cr	₹150 Cr
₹1437 Cr	₹976 Cr	₹782 Cr	₹650 Cr
₹109	₹3,217	₹2,310	₹2,167
₹109	₹643	₹462	₹433

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023
₹97 Cr	₹87 Cr	₹33 Cr	-₹9 Cr
₹168 Cr	₹93 Cr	₹80 Cr	₹69 Cr
-₹6 Cr	-₹44 Cr	-₹33 Cr	-₹53 Cr
₹260 Cr	₹136 Cr	₹80 Cr	₹7 Cr
₹233 Cr	₹135 Cr	₹72 Cr	₹11 Cr
-₹410 Cr	-₹125 Cr	-₹51 Cr	-₹78 Cr
₹157 Cr	₹54 Cr	₹27 Cr	₹60 Cr
-₹21 Cr	₹65 Cr	₹48 Cr	-₹7 Cr
₹126 Cr	₹61 Cr	₹14 Cr	₹19 Cr
₹19 Cr	₹2 L	-₹1 Cr	₹2 Cr
₹124 Cr	₹126 Cr	₹61 Cr	₹14 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Nephrocare Health Services Share Price

630.25+5.65 (+0.90%)

+33.74% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 3

Bearish signals: 4 out of 9 oscillators

RSI

47.00Neutral

STOCH %K

84.26Sell

MACD Level(12,26)

-12.17Sell

Ultimate Oscillator

64.63Buy

Aroon Oscillator

-54.00Sell

BOP

0.13Buy

CCI

-13.15Neutral

Williams %R

-15.74Sell

Momentum

13.10Buy

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 6

Bearish signals: 3 out of 9 moving averages

EMA 9

623.06Buy

SMA 9

621.01Buy

EMA 21

630.57Sell

SMA 21

619.77Buy

EMA 50

651.96Sell

SMA 50

670.45Sell

EMA 200

608.82Buy

SMA 200

619.97Buy

WMA 20

619.16Buy

Pivot

Classic

Resistance 5

697.65

Resistance 4

679.50

Resistance 3

661.35

Resistance 2

643.20

Resistance 1

633.90

Pivot

625.05

Support 1

615.75

Support 2

606.90

Support 3

588.75

Support 4

570.60

Support 5

552.45

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

585.50

580.20

536.00

453.25

446.00

High

632.25

634.35

647.55

781.50

Returns

+5.65

+15.70

-7.40

-61.40

+85.30

+161.55

—

+140.25

Beta

—

Std. deviation %

—

Open a free Demat account in minutes to start investing and screening .

Nephrocare Health Services Share Price

630.25+5.65 (+0.90%)

+33.74% past 1 Year

Shareholding summary

Promoters

58.31%

FII

11.73%

DII

4.18%

3.93%

Others

21.85%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025
58.31%	63.85%	63.85%	63.85%
11.73%	8.78%	9.94%	3.59%
4.18%	5.85%	5.47%	4.31%
3.93%	3.20%	3.17%	3.44%
21.85%	18.32%	17.57%	24.81%

Bulk & block deals

Name

Edoras Investment Holdings Pte Ltd

Mansi Share And Stock Broking Private Limited

Polar Capital Funds Plc-Healthcare Opportunities Fund

Edoras Investment Holdings Pte Ltd

Rajasthan Global Securities Pvt Ltd

Polar Capital Funds Plc-Healthcare Opportunities Fund

Marwadi Chandarana Intermediaries Brokers Private Limited

Mansi Share And Stock Broking Private Limited

Poonawalla Vision Fund I

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
24 Sep 2026	Sell	59.80 Cr	₹710.18	8.42 L	Bulk	0.83925	NSE
24 Sep 2026	Sell	57.96 Cr	₹710.45	8.16 L	Bulk	0.813006	NSE
24 Sep 2026	Purchase	58.06 Cr	₹705.24	8.23 L	Bulk	0.820515	NSE
24 Sep 2026	Purchase	179.47 Cr	₹705	25.46 L	Bulk	2.537075	NSE
24 Sep 2026	Sell	59.37 Cr	₹705.03	8.42 L	Bulk	0.83925	NSE
17 Dec 2025	Purchase	2.46 Cr	₹491	50 K	Bulk	0.049834	NSE
17 Dec 2025	Purchase	165.14 Cr	₹481.77	34.28 L	Bulk	3.416472	NSE
17 Dec 2025	Purchase	25.78 Cr	₹482.75	5.34 L	Bulk	0.53222	NSE
17 Dec 2025	Purchase	27.93 Cr	₹490	5.70 L	Bulk	0.568125	NSE
17 Dec 2025	Purchase	29.89 Cr	₹490.05	6.10 L	Bulk	0.607972	NSE

Insider trading & SAST

Client name

Polar Capital Funds Plc & Others

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
19 Jan 2026	Other	Acquisition	0.21	5.05	0	—	2.14 L	19 Dec 2025	Market	50,74,256	SAST	29(1)	—

Nephrocare Health Services Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Nephrocare Health Services Share Price

Nephrocare Health Services Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Nephrocare Health Services Share Price

Nephrocare Health Services Share Price

Oscillators

Moving averages

Nephrocare Health Services Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Nephrocare Health Services Share Price

Corporate Actions

Company details

Nephrocare Health Services Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Nephrocare Health Services Share Price

News

NephroPlus Reports Q2 Net Profit After Prior Year Loss

NephroPlus Reports Strong Second Quarter Revenue Growth Year On Year

Nephrocare Health Services Reports Rs 409 Crore NSE Block Trade

Nephrocare Health Services Schedules Analyst And Investor Meeting On September 29

Nephrocare Health to acquire dialysis facility assets in the Philippines

Nephrocare Health buys full ownership of Almaty dialysis centre

Nephrocare Health reiterates medium term growth outlook of 15 to 20 percent

Nephrocare Health Services reports higher Q1 EBITDA and stable margin

Nephrocare Health Services reports Q1 revenue growth to Rs 280 crores

Nephrocare Health Services reports higher Q1 net profit year on year

Nephrocare Health Services sees Rs 70 crore block trade in NEPHROPLUS stock

Nephrocare Health Services to acquire Philippines dialysis center assets

Nephrocare Health trades higher on the BSE

Nephrocare Health shines as its arm inks asset transfer pact with Amica Healthcare System Corporation

Nephrocare Health’s arm inks asset transfer pact with Amica Healthcare System Corporation

Nephrocare Health arm acquires Philippines dialysis assets to expand global footprint

Nephrocare Health jumps as its arm inks asset transfer pact with Inocentes Dialysis Clinic

Nephrocare Health’s arm inks asset transfer pact with Inocentes Dialysis Clinic

Nephrocare Health Services unit signs asset transfer deal with Inocentes Dialysis Clinic

Nephrocare Health Services rises as its arm incorporates wholly-owned subsidiary in Kazakhstan

Nephrocare Health Services Ltd Share Price Today

Nephrocare Health Services Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator